News Release

Notice of Exercise Price of Stock Option etc

• GNI Receives Important Patent Grants in China for Pirfenidone(F647) and in Australia for F351
• The NIKKAN KOGYO SHIMBUN newspaper of Japan published an article describing the fast-expanding CRO business in China. Dr. Ying Luo, CEO of GNI and Shanghai Genomics, is quoted in the article. A picture of the company’s research facility is also